Proteomics of autism and Alzheimer’s mouse models reveal common alterations in mTOR signaling pathway
Authors:
Open Access
- 17 September 2021
- journal article
- research article
- Published by Springer Nature in Translational Psychiatry
- Vol. 11 (1) , 1-10
Abstract
Autism spectrum disorder (ASD) and Alzheimer’s disease (AD) are two different neurological disorders that share common clinical features, such as language impairment, executive functions, and motor problems. A genetic convergence has been proposed as well. However, the molecular mechanisms of these pathologies are still not well understood. Protein S-nitrosylation (SNO), the nitric oxide (NO)-mediated posttranslational modification, targets key proteins implicated in synaptic and neuronal functions. Previously, we have shown that NO and SNO are involved in the InsG3680(+/+) ASD and P301S AD mouse models. Here, we performed large-scale computational biology analysis of the SNO-proteome followed by biochemical validation to decipher the shared mechanisms between the pathologies. This analysis pointed to the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway as one of the shared molecular mechanisms. Activation of mTOR in the cortex of both mouse models was confirmed by western blots that showed increased phosphorylation of RPS6, a major substrate of mTORC1. Other molecular alterations affected by SNO and shared between the two mouse models, such as synaptic-associated processes, PKA signaling, and cytoskeleton-related processes were also detected. This is the first study to decipher the SNO-related shared mechanisms betweenSHANK3andMAPTmutations. Understanding the involvement of SNO in neurological disorders and its intersection between ASD and AD might help developing an effective novel therapy for both neuropathologies.Keywords
This publication has 109 references indexed in Scilit:
- NYAP: a phosphoprotein family that links PI3K to WAVE1 signalling in neuronsThe EMBO Journal, 2011
- Increased Secreted Amyloid Precursor Protein-α (sAPPα) in Severe Autism: Proposal of a Specific, Anabolic Pathway and Putative BiomarkerPLOS ONE, 2011
- Resistance to change and vulnerability to stress: autistic‐like features of GAP43‐deficient miceGenes, Brain and Behavior, 2010
- Dysregulation of the mTOR Pathway Mediates Impairment of Synaptic Plasticity in a Mouse Model of Alzheimer's DiseasePLOS ONE, 2010
- Synapse Pathology in Psychiatric and Neurologic DiseaseCurrent Neurology and Neuroscience Reports, 2010
- Serotonin 5- Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular DiseasesCardiovascular Psychiatry and Neurology, 2009
- A complex interplay between Akt, TSC2 and the two mTOR complexesBiochemical Society Transactions, 2009
- Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouseHuman Molecular Genetics, 2009
- Amyloid Precursor Protein Trafficking, Processing, and FunctionJournal of Biological Chemistry, 2008
- Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTipsNature Protocols, 2007